mTORC1 activation in lung mesenchyme drives sex- and age-dependent pulmonary structure and function declineKseniya Obraztsova, Vera P. Krymskaya, Edward Cantu et al.|Nature Communications|2020Cited by 58
Hyperactive mTORC1 in lung mesenchyme induces endothelial cell dysfunction and pulmonary vascular remodelingSusan M. Lin, Vera P. Krymskaya, Ryan W. Rue et al.|Journal of Clinical Investigation|2023Cited by 18
The Bi-steric Inhibitor RMC-5552 Reduces mTORC1 Signaling and Growth in LymphangioleiomyomatosisJilly F. Evans, Vera P. Krymskaya, O. Ledwell et al.|American Journal of Respiratory Cell and Molecular Biology|2024Cited by 7
Extracellular Matrix and Fibroblast Activation in LymphangioleiomyomatosisAlexander R. Mukhitov, Vera P. Krymskaya, Jilly F. Evans et al.|American Journal of Respiratory Cell and Molecular Biology|2025Cited by 1
Dysfunctional Alveolar Repair and Pro-fibrotic Remodeling in Lymphangioleiomyomatosis (LAM)Kseniya Obraztsova, Vera P. Krymskaya, Alexander R. Mukhitov et al.|Unknown|2023Cited by 0